Recent Headlines
PD-1 and PD-L 1 Inhibitors – Competitive Landscape, Pipeline and Market Analysis, 2016
DelveInsight has a strong presence in the Oncology market with 100+ Reports on Oncology based Indications & Mechanism of Action (MOA). DelveInsight Report, PD-1 and PD-L 1 Inhibitors – Competitive Landscape, Pipeline and Market Analysis, 2016 has received great response and feedback from clients. - February 19, 2016 - DelveInsight
Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2016
DelveInsight, the leading market research and consulting company has added a new report “Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2016” to its portfolio. - February 19, 2016 - DelveInsight
ALPCO Releases New Basophil Activation Test Validated for the Evaluation of Kinase Inhibitors in Early Drug Development
ALPCO has released its new InhibiScreen Basophil Activation Test (BAT) which was developed and validated specifically for the evaluation of kinase inhibitors during early drug development. - February 16, 2016 - ALPCO
Tabula Rasa Healthcare Pharmacy Simulation Software Tested by Schools of Pharmacy
Medication treatment is the most common medical intervention. Its imprecise use contributes to an estimated 45-50 million adverse drug events annually. Tabula Rasa's suite of software solutions provide prescribers, pharmacists and healthcare organizations with sophisticated and innovative tools to better manage the medication-related needs of patients. NiaRx provides electronic health record training and patient-case simulation for pharmacy students, the future of tomorrow's caregiving team. - February 15, 2016 - Tabula Rasa HealthCare
Real Endpoints’ RxScorecard™ Predicted Launch Failure of Major New Anti-Cholesterol Drugs
Analysis from 2015 showed that because PCSK9 inhibitors had not proved more than incremental value for most patients, payers would dramatically restrict their usage. Poor Q4 sales show that’s exactly what happened. - February 12, 2016 - Real Endpoints
Studies Use Epitope Diagnostics’ ELISA Kit to Establish Chromogranin A as a Potential Prognostic Marker in Prostate Cancer Patients Treated with Antiandrogens
Italian research group uses Epitope Diagnostics' Chromogranin A ELISA kit in study to determine CgA as a potential prognostic marker in castration-resistant prostate cancer patients treated in abiraterone or enzalutamide. - February 11, 2016 - Epitope Diagnostics, Inc.
Advanced Electrophoresis Solutions Signs an Exclusive Distributor Partner for Europe
AES (Advanced Electrophoresis Solutions Ltd.), a pioneer in designing and manufacturing the most reliable, high performance, and high throughput CEInfinite whole column imaging detection capillary isoelectric focusing (iCIEF) systems, proprietary cartridges, ampholytes, and pI standards for the... - February 11, 2016 - Advanced Electrophoresis Solutions Ltd.
PD-1 and PD-L 1 inhibitors – Competitive Landscape, Pipeline and Market Analysis, 2016
DelveInsight has made strong presence in Oncology market with 100+ Reports on Oncology-based Indications & Mechanism of Action (MOA). - February 10, 2016 - DelveInsight
Bioquark Inc. and Revita Life Sciences to Collaborate on Regenerative Medicine Applications in Spinal Cord Injury
Bioquark Inc., a cutting edge life sciences company focused on the development of a novel biologic portfolio of products, services, and technologies for complex regeneration, disease reversion, and aging in humans, is entering a collaboration with India's Revita Life Sciences to advance translational opportunities in spinal cord injury repair. - February 06, 2016 - Bioquark Inc.
Noninvasix Secures Finalist Slot in Healthcare Innovation Challenges
CEO Graham Randall to present patient monitoring device at SPIE Startup Challenge, Pediatric Device Innovation Competition. - February 03, 2016 - Noninvasix
New Company Providing Paint Services for Manufacturers Hosts Open House Showcasing Highly Automated Line in Cheney, Kansas
Albers Finishing & Solutions provides liquid paint services to regional and national customers. the liquid paint line is capable of painting 2,000 to 3,000 parts per day and features an automated conveyor that moves load bars forward and reverse or even stops them independently of the other load bars, a three-stage wash, dry off oven, two paint booths with Fanuc robots applying liquid primer and paint, a dual-lane energy-efficient cure oven and a load-assist lifter. - February 02, 2016 - Kasa Companies
Speaking of NEC Podcast Featuring Dr. Corrine Hanson Recently Launched
Produced by The Morgan Leary Vaughan Fund, and funded by The Petit Family Foundation, Speaking of NEC is a series of one-on-one conversations with relevant NEC experts - neonatologists, clinicians and researchers - that highlights current prevention, diagnosis, and treatment strategies for NEC, and the search for a cure. - February 02, 2016 - The Morgan Leary Vaughan Fund, Inc.
Coalition Forms to Study Medication Risk in Workforce Populations
Tabula Rasa HealthCare and The Greater Philadelphia Business Coalition on Health have partnered to examine the extent of medication risk in a diverse workforce population and the opportunities to mitigate that risk for the benefit of improving the health and welfare of employees and reducing unnecessary health care costs. - February 01, 2016 - Tabula Rasa HealthCare
aiaTranslations Offering Discounts to Healthcare Associations
As part of the annual patient access drive, aiaTranslations, the leader in life sciences translation services, is offering discounted translation pricing to patient advocacy and education non-profits. - January 29, 2016 - aiaTranslations LLC
Chimeric Antigen Receptor (CAR) T Cell Immunotherapy - Competitive Landscape, Technology and Pipeline Analysis, 2016
DelveInsight, the leading market research and consulting company has added new report “Chimeric Antigen Receptor (CAR) T cell Immunotherapy - Competitive Landscape, Technology and Pipeline Analysis, 2016” to its portfolio. CAR-T cells are the next targeted agents in Oncology. CAR-T... - January 29, 2016 - DelveInsight
ALPCO's New Stool-Based Gastroenterology Assays and Extraction Method Can Improve Lab Sample Processing Time by Up to 86%
ALPCO recently launched a new panel of 13 stool-based gastroenterology assays that are all compatible with one single extraction step, allowing labs to improve sample processing time by up to 86%. - January 26, 2016 - ALPCO
Use of Care Plans Boosts Patient Adherence, Engagement, Quality Metrics
The use of care plans improves medication adherence, patient self-management and clinical quality ratings, say a majority of respondents to a 2015 survey by the Healthcare Intelligence Network (HIN). - January 26, 2016 - Healthcare Intelligence Network
Eagle Biosciences Announces the Launch of Functional Leptin ELISA
An Esoteric Kit for Measurement of Functional, Receptor Binding Leptin Levels in Serum or Plasma - January 25, 2016 - Eagle Biosciences, Inc.
Asian Patent Acceptances Enhance Braasch Biotech Livestock Portfolio
New paradigm of using vaccines to enhance productivity in livestock, Braasch Biotech continues portfolio expansion - January 21, 2016 - Braasch Biotech LLC
Steve Cotter Releases Online Interactive Kettlebell Training
Steve Cotter, one of the world’s preeminent kettlebell instructors is pleased to announce the release of Steve Cotter’s Kettlebell University™. The Kettlebell University™ is a membership based, online, interactive training system for Members of all ages and fitness levels organized in 3 modules, Kettlebell Training, Nutrition, and The Science of Fitness. - January 20, 2016 - Steve Cotter's Kettlebell University™
Dr. Cali Estes of The Addictions Academy Featured in the First Starter Kit to Recovery at Home
In a Program Series that is the first of its kind, Dr. Cali Estes has been featured in the Starter Kit to Recovery. The program is designed for those that can not afford traditional addiction treatment services. - January 17, 2016 - The Addictions Academy
Atomo Diagnostics Secures US$6M Investment from The Global Health Investment Fund
The Global Health Investment Fund (GHIF) announced today that it has provided a US$6 million [A$8.5 million] loan to Atomo Diagnostics (Atomo) to support scale-up of Atomo’s production operations and expansion of commercial activities related to the AtomoRapid™ rapid diagnostic test (RDT) platform. Funds will also be used to commercialise a self-test solution for HIV and other infectious diseases. - January 16, 2016 - Atomo Diagnostics
Pancreatic Cancer-Pipeline Insights, 2016- A DelveInsight Report
DelveInsight, the leading market research and consulting company has added new report Pancreatic Cancer-Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. In addition to this their research expertise provides their clients... - January 15, 2016 - DelveInsight
Peripheral Lung Cancer-Pipeline Insights, 2016
DelveInsight, the leading market research and consulting company has added new report Peripheral Lung Cancer-Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. In addition to this our research expertise provides our clients... - January 14, 2016 - DelveInsight
Drug Safety Company Expands Operations
Drug Safety Navigator, LLC (DSN) Announces Another Expansion in Its Fifth Year of Operation - January 13, 2016 - Drug Safety Navigator, LLC
Hula Health Making "Waves" in Health and Nutrition
Health Supplement Company Announces Launch. - January 13, 2016 - Hula Health
Novant Health to Detail Pharmacist-Driven Post-Discharge Drug Therapy Management Effort for High-Risk Patients in February 3, 2016 Webinar
A February 3, 2016 webinar will explore Novant Health's clinical pharmacist-driven medication management effort that identifies patients at high risk for readmissions or ED visits related to adverse drug events. - January 13, 2016 - Healthcare Intelligence Network
DelveInsight's Market Research Reports, 2016
DelveInsight has established its strong presence in therapeutic areas and has launched Analytical Reports on indication, mechanism of actions, drugs, Global API Manufacturers and specialized Reports on Gene Therapy, Anticoagulants, PD-1 and PDL-1, CART and Antibody Drug conjugates. After... - January 13, 2016 - DelveInsight
BÜHLMANN Laboratories Opens North American Affiliate
BÜHLMANN Laboratories is proud to announce the availability of its products directly from its new North American affiliate, BUHLMANN Diagnostics Corp (BDC) in Southern New Hampshire. - January 11, 2016 - BUHLMANN Diagnostics Corp
Largest U.S. Sponsor of Medicare ACOs to Share Data Analytics Tactics for Accountable Care During January 27, 2016 Webinar
Collaborative Health Systems, the nation's largest sponsor of Medicare Shared Savings ACOs, will share how data analytics has improved accountable care results during a January 27, 2016 webinar sponsored by the Healthcare Intelligence Network. - January 07, 2016 - Healthcare Intelligence Network
New Supplement Company Focuses on Successful Middle-Aged Men
A new supplement company called Silver Wolf Nutrition is being launched in 2016 to provide successful, middle-aged men with specific solutions to help them increase their longevity. The company did extensive research to produce a line of supplements that solve the specific issues that educated men aged 35 to 55 years old face on a regular basis. This includes natural remedies for enhanced workout energy, focus, sleep, muscle development and retention, and more. - January 06, 2016 - Silver Wolf Nutrition
January 26 Webinar to Examine Physician Reimbursement in 2016: Workflow Optimization for Chronic Care Management and Advance Care Planning
Bon Secours Medical Group will describe its approach to chronic care management reimbursement and positioning for billable advance care planning in 2016 during a January 26, 2016 webinar sponsored by the Healthcare Intelligence Network. - January 05, 2016 - Healthcare Intelligence Network
Speaking of NEC Podcast Featuring Dr. Sergio Golombek Recently Launches
Produced by The Morgan Leary Vaughan Fund, and funded by The Petit Family Foundation, Speaking of NEC is a series of one-on-one conversations with relevant NEC experts—neonatologists, clinicians and researchers—that highlights current prevention, diagnosis, and treatment strategies for NEC, and the search for a cure. - January 01, 2016 - The Morgan Leary Vaughan Fund, Inc.
2016 Healthcare Trends: Population Health Prevails in Pay-for-Value Realm
Population health management remains the most influential factor in healthcare business operations for the second consecutive year, according to a complimentary trends snapshot by the Healthcare Intelligence Network (HIN). - December 15, 2015 - Healthcare Intelligence Network
Speaking of NEC Podcast Featuring Neonatal Ergonomics Expert Yamile Jackson Recently Launched
Produced by The Morgan Leary Vaughan Fund, and funded by The Petit Family Foundation, Speaking of NEC is a series of one-on-one conversations with relevant Necrotizing Enterocolitis (NEC) experts-neonatologists, clinicians and researchers-that highlights current prevention, diagnosis, and treatment strategies for NEC, and the search for a cure. - December 03, 2015 - The Morgan Leary Vaughan Fund, Inc.
Sydney Company Wins State Funding to Make HIV Self Test
Atomo Diagnostics awarded A$1.8 mil from the NSW Medical Device Fund to develop innovative HIV self test in Australia. - November 28, 2015 - Atomo Diagnostics
Best Practices for Antibiotic Use
Antibiotic resistance is one of the largest health issues facing the world in the next few years. Earlier this month, the World Health Organization held Global Antibiotic Awareness Week. Aceso Care worked to translate content released by the World Health Organization into Urdu to spread awareness... - November 28, 2015 - Aceso Care
Noninvasix Among Finalists in 2015 HITLAB World Cup℠ International Healthcare Competition
Of the more than 192 international teams that submitted innovative healthcare solutions, five companies, including Noninvasix, Inc., will compete for $18,000 in total prize money at the HITLAB World Cup℠ finals held at Columbia University in New York City, December 4. Organized by New York... - November 21, 2015 - Noninvasix
Update on Glycomics - Achieve Safe, Easy, and Accurate O-Glycan Analysis with BlotGlyco® O-Glycan Sample Preparation Kit
MoBiTec to launch Sumitomo's BlotGlyco® O-Glycan Sample Preparation Kit, a streamlined process for releasing and purifying O-glycans for detection by HPLC, LC-MS, and MALDI-TOF MS. - November 19, 2015 - MoBiTec GmbH
EternoGen Aesthetics Completes Its Financing Round Securing $5MM to Commercialize Their First in Class Bio-Dermal Restoration Portfolio
EternoGen Aesthetics, LLC developer and manufacturer of advanced collagen scaffolds, announces the successful completion of its financial round. It has secured $5MM to prepare for the 2016 European commercialization of Rapid Polymerizing Collagen (RPC Pure-Collagen), the first of a rich pipeline of... - November 18, 2015 - EternoGen Aesthetics LLC
New Metrics on Value-Based Healthcare: Adopters Report Healthy Savings, Prevention Gains
Seventy-one percent of healthcare companies employ value-based reimbursement strategies, with one-fifth reporting savings of up to $500,000 annually, according to new market metrics from the Healthcare Intelligence Network (HIN). - November 17, 2015 - Healthcare Intelligence Network
BUHLMANN Laboratories Announces New, Direct US Affiliate
BÜHLMANN Laboratories is proud to announce the establishment of its North American affiliate, BUHLMANN Diagnostics Corp (BDC) in Southern New Hampshire. - November 16, 2015 - BUHLMANN Diagnostics Corp
LifeFuels Smart Nutrition Bottle Named 2016 CES Innovation Awards Honoree
Award-winning connected health and fitness product bridges crucial gap between nutrition and wearable technology; First portable, single and multi-serve device that gives users the personalized nutrition and hydration they need, when they need it. - November 14, 2015 - LifeFuels
New Acid Catalyst Offers Significant Cost Reductions with Increased Stability
An exciting new acid catalyst from PhosphonicS could help significantly reduce costs and minimise losses in the Pharmaceutical and Chemical industries. The recently launched Phos-Cat4 has been specially designed to be just as effective as the rest of the PhosphonicS acid catalyst range but offer... - November 12, 2015 - PhosphonicS
New Year, New Look - Sorbead India Launched New Website Theme
The new website theme is more accessible and easy-to-use compared to the previous one. It has got a brand new look with everything becoming more trendy and user friendly. - November 09, 2015 - Sorbead India
Mid-Florida Integrative Medicine Hosts Essential Oils Event
Top Natural Health Dr. in Orlando met with consumers to share information about the benefits of essential oils. - November 06, 2015 - Mid-Florida Integrative Medicine
CEL Nutrition Introduces Nootropic in the Fight Against Prescription Drugs
CEL Nutrition launches NervaCORE in the hopes of providing an all-natural alternative to cognitive-enhancing drugs. - November 04, 2015 - CEL Nutrition
Better Medicare Alliance Hires Capitol Hill Veteran to Lead Communications
The Better Medicare Alliance (BMA), a leading advocacy coalition dedicated to supporting and strengthening the Medicare Advantage program, announced it has hired Adjoa Adofo as Communications Director. - November 04, 2015 - Better Medicare Alliance
AOA, AANP, AND NMA Join Better Medicare Alliance
Coalition Grows to 31 Organizations in Support of Medicare Advantage; Adds Local, State Health and Business Groups Twelve more organizations including representatives of nurse practitioners, osteopathic physicians, and African American physicians have joined the Better Medicare Alliance (BMA), a... - November 04, 2015 - Better Medicare Alliance
Consumer Health Brands Introduces DEFY®, a Functional Health Mix to Enhance Alcohol Metabolism
Consumer Health Brands, Inc. (www.DEFYMIX.com), a Silicon Valley-based provider of vitamin and nutritional products for the active social lifestyle, today announced DEFY®, a functional health powder mix designed to enhance alcohol metabolism and help next-day mental alertness. Be Social. Feel... - November 01, 2015 - Consumer Health Brands, Inc.